Control group:Whole brain radiotherapy

3 trials

Sponsors

Department of Oncology, The Second People's Hospital of Yibin, Beijing Tiantan Hospital, Capital Medical University, Chengdu Fifth People's Hospital

Conditions

Brain metastasesNon-small cell lung cancer with brain metastasesprimary central nervous system lymphoma

Early Phase 1

The efficacy and safety of anlotinib combined with whole brain radiotherapy in the treatment of brain metastases from non-small cell lung cancer with EGFR wild type

RecruitingChiCTR2400080841

Chengdu Fifth People's HospitalNon-small cell lung cancer with brain metastases

Start: 2023-09-22Updated: 2024-02-11

Phase 4

A prospective randomized controlled trial of apatinib in the treatment of brain metastases with moderate to severe peritumoral edema

Active, not recruitingChiCTR2000031785

Department of Oncology, The Second People's Hospital of YibinBrain metastases

Start: 2020-05-01Updated: 2020-04-13

Unknown Phase

Comparison of efficacy between high dose chemotherapy and whole brain radiotherapy in primary central nervous system lymphoma with induction remission: a prospective, randomized, evaluator-blinded clinical trial

RecruitingChiCTR2100041905

Beijing Tiantan Hospital, Capital Medical Universityprimary central nervous system lymphoma

Start: 2021-01-09Updated: 2021-03-30

Related Papers

A pharmacodynamic study of rapid lactate metabolic modulation by intravenous L-arginine in brain metastases

Frontiers in Oncology2026-05-28